An entirely novel nanoparticle carrying a bioactive shRNA molecule (DFP-10825) could be clinically effective against the high risk patients with mesothelioma relapsed or refractory after treatment with pemetrexed based chemotherapy.

An entirely novel nanoparticle carrying a bioactive shRNA molecule (DFP-10825) could be clinically effective against the high risk patients with mesothelioma relapsed or refractory after treatment with pemetrexed based chemotherapy.
复制标题

一种携带生物活性shRNA分子的全新纳米颗粒(DFP-10825)可以在临床上有效地治疗经培美曲塞化疗后复发或难治的间皮瘤高危患者。

DOI:
--
复制
发表时间:
2012
期刊:
影响因子:
--
通讯作者:
T.,
T.,
中科院分区:
--
文献类型:
--
作者:
Ishida;T.,

文献摘要

相似文献